<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/wp-content/plugins/xml-sitemap-feed/assets/sitemap-news.xsl?ver=5.7.7"?>
<!-- generated-on="2026-11-22T17:38:47+00:00" -->
<!-- generator="XML Sitemap & Google News for WordPress" -->
<!-- generator-url="https://status301.net/wordpress-plugins/xml-sitemap-feed/" -->
<!-- generator-version="5.7.7" -->
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" >
<url><loc>https://news.medxy.ai/ja/advancing-global-body-literacy/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:37:49-08:00</news:publication_date><news:title>身体リテラシーを世界で前進させる：GloPL行動枠組みの合意形成と実践提言</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/global-physical-literacy-framework-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:37:19-08:00</news:publication_date><news:title>Khung hành động năng lực vận động toàn diện toàn cầu (GloPL): Quy trình đồng thuận và khuyến nghị thực tiễn</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/global-physical-literacy-framework/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:36:49-08:00</news:publication_date><news:title>全球身体素养（GloPL）行动框架：共识形成过程与实践建议</news:title></news:news></url>
<url><loc>https://news.medxy.ai/the-global-physical-literacy-glopl-action-framework-consensus-process-and-practical-recommendations/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:36:26-08:00</news:publication_date><news:title>The Global Physical Literacy (GloPL) Action Framework: Consensus Process and Practical Recommendations</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/low-back-pain-rehabilitation-priorities/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:35:23-08:00</news:publication_date><news:title>腰痛康复优先级如何与居家和工作功能对齐：来自利益相关者驱动群体概念映射研究的启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/low-back-pain-rehabilitation-priorities-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:35:04-08:00</news:publication_date><news:title>腰痛リハビリテーションにおける優先順位を、家庭や職場での機能とどのように整合させるか？</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/rehabilitation-for-low-back-pain/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:34:41-08:00</news:publication_date><news:title>Ưu tiên phục hồi chức năng để cải thiện khả năng hoạt động tại nhà và nơi làm việc ở người đau thắt lưng: Những phát hiện từ nghiên cứu lập bản đồ khái niệm nhóm có sự tham gia của các bên liên quan</news:title></news:news></url>
<url><loc>https://news.medxy.ai/aligning-rehabilitation-priorities-to-enhance-home-and-work-functioning-in-low-back-pain-insights-from-a-stakeholder-driven-group-concept-mapping-study/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:34:24-08:00</news:publication_date><news:title>Aligning Rehabilitation Priorities to Enhance Home and Work Functioning in Low Back Pain: Insights from a Stakeholder-Driven Group Concept Mapping Study</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/pulp-diagnosis-confidence/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:33:43-08:00</news:publication_date><news:title>提升牙髓病学诊断信心：患者视角下的锥形束计算机断层扫描与辐射认知</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/cbct-endodontics-diagnostic-reliability-radiation-perception-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:33:25-08:00</news:publication_date><news:title>歯内療法における診断の確信度向上：患者の視点から見たコーンビームCTと放射線に対する認識</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/cbct-endodontics-diagnostic-reliability-radiation-perception/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:33:08-08:00</news:publication_date><news:title>CBCT trong nội nha: tăng độ tin cậy chẩn đoán và góc nhìn của bệnh nhân về bức xạ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/enhancing-diagnostic-confidence-in-endodontics-patient-perspectives-on-cone-beam-computed-tomography-and-radiation-awareness/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:32:53-08:00</news:publication_date><news:title>Enhancing Diagnostic Confidence in Endodontics: Patient Perspectives on Cone-Beam Computed Tomography and Radiation Awareness</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/empirical-tuberculosis-treatment/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:32:14-08:00</news:publication_date><news:title>非洲 HIV 感染重症肺炎婴儿经验性结核病治疗：EMPIRICAL 多中心随机试验综述</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/empirical-tuberculosis-treatment-review/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:31:52-08:00</news:publication_date><news:title>アフリカのHIV感染乳児重症肺炎に対する経験的結核治療：EMPIRICAL試験の包括的レビュー</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/empirical-tuberculosis-treatment-infants-hiv-pneumonia/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:31:27-08:00</news:publication_date><news:title>Điều trị lao kinh nghiệm ở trẻ nhũ nhi nhiễm HIV nhập viện vì viêm phổi nặng tại châu Phi (EMPIRICAL): Tổng quan toàn diện về một thử nghiệm ngẫu nhiên có đối chứng đa trung tâm</news:title></news:news></url>
<url><loc>https://news.medxy.ai/empirical-tuberculosis-treatment-in-infants-living-with-hiv-hospitalised-with-severe-pneumonia-in-africa-empirical/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:31:09-08:00</news:publication_date><news:title>Empirical Tuberculosis Treatment in Infants Living with HIV Hospitalised with Severe Pneumonia in Africa (EMPIRICAL): A Comprehensive Review of a Multicentre Randomised Controlled Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/increased-mental-health-diagnoses/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:30:15-08:00</news:publication_date><news:title>复杂慢性病儿童精神卫生诊断率升高：筛查与公平性的新启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/mental-health-diagnoses-in-chronically-ill-children/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:29:58-08:00</news:publication_date><news:title>複雑慢性疾患を有する子どもにおける精神保健診断の高頻度：スクリーニングと公平性への示唆</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/mental-health-diagnostic-burden/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:29:39-08:00</news:publication_date><news:title>Gánh nặng chẩn đoán sức khỏe tâm thần tăng cao ở trẻ em mắc bệnh mạn tính phức tạp: Hàm ý cho sàng lọc và công bằng y tế</news:title></news:news></url>
<url><loc>https://news.medxy.ai/elevated-mental-health-diagnosis-prevalence-among-children-with-complex-and-chronic-medical-conditions-implications-for-screening-and-equity/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:29:22-08:00</news:publication_date><news:title>Elevated Mental Health Diagnosis Prevalence Among Children With Complex and Chronic Medical Conditions: Implications for Screening and Equity</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/pediatric-cns-vasculitis-guidelines/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:28:39-08:00</news:publication_date><news:title>小児CNS血管炎に対する新たなERN‑RITA/PReS推奨：診断・分類・モニタリング・治療を支える実践的な小児中心ガイド</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/pediatric-cns-vasculitis-guidelines-3/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:28:06-08:00</news:publication_date><news:title>Khuyến cáo mới ERN‑RITA/PReS về viêm mạch CNS ở trẻ em: Hướng dẫn thực hành, lấy nhi khoa làm trung tâm cho chẩn đoán, phân loại, theo dõi và điều trị</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/pediatric-cns-vasculitis-guidelines-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:27:32-08:00</news:publication_date><news:title>儿童CNS血管炎迎来首份国际循证指南：从诊断到治疗的实用儿科路径</news:title></news:news></url>
<url><loc>https://news.medxy.ai/childhood-cns-vasculitis-guidelines/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:27:05-08:00</news:publication_date><news:title>New ERN‑RITA/PReS Recommendations for Childhood CNS Vasculitis: Practical, Paediatric‑Centric Guidance for Diagnosis, Classification, Monitoring and Treatment</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/early-impact-pediatric-lung-transplantation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:26:09-08:00</news:publication_date><news:title>综合分配评分对儿科肺移植结局的早期影响：进展与挑战</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/early-composite-allocation-impact/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:25:51-08:00</news:publication_date><news:title>Composite Allocation Score導入が小児肺移植にもたらした初期効果：進展と課題</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/initial-impact-composite-allocation-score-lung-transplantation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:25:30-08:00</news:publication_date><news:title>Tác động ban đầu của Composite Allocation Score đối với kết cục ghép phổi nhi khoa: tiến bộ và thách thức</news:title></news:news></url>
<url><loc>https://news.medxy.ai/early-impact-of-the-composite-allocation-score-on-pediatric-lung-transplantation-outcomes-advances-and-challenges/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:25:14-08:00</news:publication_date><news:title>Early Impact of the Composite Allocation Score on Pediatric Lung Transplantation Outcomes: Advances and Challenges</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/postmastectomy-sensory-restoration/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:24:38-08:00</news:publication_date><news:title>乳房切除术后感觉重建：靶向乳头再神经化的临床启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/postmastectomy-sensory-restoration-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:24:17-08:00</news:publication_date><news:title>乳房切除術後の感覚再建：乳頭の再神経化を標的とした臨床的示唆</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/postmastectomy-nerve-regeneration/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:23:52-08:00</news:publication_date><news:title>Phục hồi cảm giác sau cắt bỏ tuyến vú khẳng định giới tính: những phát hiện từ tái phân bố thần kinh có mục tiêu cho núm vú</news:title></news:news></url>
<url><loc>https://news.medxy.ai/restoring-sensation-after-gender-affirming-mastectomy-insights-from-targeted-nipple-reinnervation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:23:35-08:00</news:publication_date><news:title>Restoring Sensation After Gender-Affirming Mastectomy: Insights from Targeted Nipple Reinnervation</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/albumin-predicts-long-term-outcomes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:22:55-08:00</news:publication_date><news:title>白蛋白早期变化可预测接受连续肾脏替代治疗的急性肾损伤患者长期结局</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/albumin-changes-acute-kidney-injury/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:22:36-08:00</news:publication_date><news:title>急性腎障害におけるアルブミン早期変動は長期予後を予測するのか</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/early-albumin-kinetics/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:22:16-08:00</news:publication_date><news:title>Động học sớm của albumin: dấu hiệu dự báo kết cục dài hạn ở bệnh nhân tổn thương thận cấp điều trị bằng CKRT</news:title></news:news></url>
<url><loc>https://news.medxy.ai/early-albumin-dynamics-as-predictors-of-long-term-outcomes-in-acute-kidney-injury-patients-on-continuous-kidney-replacement-therapy/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:21:58-08:00</news:publication_date><news:title>Early Albumin Dynamics as Predictors of Long-Term Outcomes in Acute Kidney Injury Patients on Continuous Kidney Replacement Therapy</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/language-access-health-outcomes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:21:16-08:00</news:publication_date><news:title>语言可及性与健康结局：城市住院医师门诊中口译服务的影响</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/language-barriers-health-outcomes-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:20:54-08:00</news:publication_date><news:title>言語アクセスと健康アウトカム：都市部の研修医外来における通訳サービスの影響</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/language-barriers-health-outcomes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:20:32-08:00</news:publication_date><news:title>Rào cản ngôn ngữ và kết cục sức khỏe: Tác động của dịch vụ phiên dịch viên tại các phòng khám nội trú đô thị</news:title></news:news></url>
<url><loc>https://news.medxy.ai/language-access-and-health-outcomes-impact-of-interpreter-services-in-urban-resident-clinics/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:20:15-08:00</news:publication_date><news:title>Language Access and Health Outcomes: Impact of Interpreter Services in Urban Resident Clinics</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/standardizing-mds-trial-reports/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:19:30-08:00</news:publication_date><news:title>骨髄異形成症候群における臨床試験報告の標準化：International Consortium for MDSによる重要提言</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/standardizing-mds-trial-reports-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:19:02-08:00</news:publication_date><news:title>Chuẩn hóa báo cáo thử nghiệm lâm sàng trong hội chứng rối loạn sinh tủy: Những khuyến nghị then chốt từ International Consortium for MDS</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/mds-trial-reporting-guidelines/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:18:25-08:00</news:publication_date><news:title>骨髓增生异常综合征临床试验报告如何统一：国际 MDS 联盟的核心建议</news:title></news:news></url>
<url><loc>https://news.medxy.ai/aligning-clinical-trial-reporting-in-myelodysplastic-syndromes-key-recommendations-from-the-international-consortium-for-mds/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:18:02-08:00</news:publication_date><news:title>Aligning Clinical Trial Reporting in Myelodysplastic Syndromes: Key Recommendations from the International Consortium for MDS</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/clinical-indicators-predict-tb-transmission/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:16:58-08:00</news:publication_date><news:title>简单临床指标可预测家庭接触者结核病传播风险：秘鲁大型队列研究的新启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/tuberculosis-transmission-risk/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:16:15-08:00</news:publication_date><news:title>結核伝播リスクを示すシンプルな臨床指標：ペルー大規模コホートからの知見</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/clinical-indicators-predict-tuberculosis-transmission/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:15:48-08:00</news:publication_date><news:title>Chỉ dấu lâm sàng đơn giản có thể dự báo nguy cơ lây truyền lao ở người tiếp xúc trong hộ gia đình: Kết quả từ một đoàn hệ lớn tại Peru</news:title></news:news></url>
<url><loc>https://news.medxy.ai/simple-clinical-markers-predict-tuberculosis-transmission-risk-in-household-contacts-insights-from-a-large-peruvian-cohort/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:15:30-08:00</news:publication_date><news:title>Simple Clinical Markers Predict Tuberculosis Transmission Risk in Household Contacts: Insights from a Large Peruvian Cohort</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/glaucoma-risk-assessment/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:14:39-08:00</news:publication_date><news:title>青光眼风险评估迎来新突破：增强型多基因风险评分助力早筛与个体化管理</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/glaucoma-risk-assessment-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:14:24-08:00</news:publication_date><news:title>緑内障リスク評価を一新する：早期発見と個別化医療に向けた高精度ポリジェニック・リスクスコア</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/improving-glaucoma-risk-assessment/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:14:06-08:00</news:publication_date><news:title>Cải thiện đánh giá nguy cơ glôcôm bằng điểm nguy cơ đa gen thế hệ mới: phát hiện sớm và chăm sóc cá thể hóa</news:title></news:news></url>
<url><loc>https://news.medxy.ai/revolutionizing-glaucoma-risk-assessment-enhanced-polygenic-risk-scores-for-early-detection-and-personalized-care/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:13:50-08:00</news:publication_date><news:title>Revolutionizing Glaucoma Risk Assessment: Enhanced Polygenic Risk Scores for Early Detection and Personalized Care</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/montelukast-postoperative-pain-ineffective/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:13:09-08:00</news:publication_date><news:title>孟鲁司特对儿童腺样体扁桃体切除术后镇痛无效：随机对照试验揭示新证据</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/montelukast-ineffective-postoperative-pain/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:12:45-08:00</news:publication_date><news:title>小児アデノトンシル切除術後の疼痛軽減にモンテルカストは無効：ランダム化比較試験が示した知見</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/montelukast-postoperative-pain-children/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:12:25-08:00</news:publication_date><news:title>Montelukast không giúp giảm đau sau adenotonsillectomy ở trẻ em: bằng chứng từ một thử nghiệm ngẫu nhiên có đối chứng</news:title></news:news></url>
<url><loc>https://news.medxy.ai/montelukast-ineffective-for-pain-reduction-after-pediatric-adenotonsillectomy-insights-from-a-randomized-controlled-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:12:11-08:00</news:publication_date><news:title>Montelukast Ineffective for Pain Reduction After Pediatric Adenotonsillectomy: Insights from a Randomized Controlled Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/primary-tumor-biology/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:11:33-08:00</news:publication_date><news:title>原发肿瘤生物学可预测结直肠肝转移切除后的复发与生存：BIO-CRLM 研究启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/primary-tumor-biology-3/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:11:10-08:00</news:publication_date><news:title>大腸癌肝転移切除後の再発・生存を左右する原発腫瘍生物学：BIO-CRLM研究からの示唆</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/primary-tumor-biology-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:10:51-08:00</news:publication_date><news:title>Sinh học khối u nguyên phát dự báo tái phát và sống còn sau phẫu thuật cắt di căn gan do ung thư đại trực tràng: Góc nhìn từ nghiên cứu BIO-CRLM</news:title></news:news></url>
<url><loc>https://news.medxy.ai/primary-tumor-biology-predicts-recurrence-and-survival-outcomes-after-colorectal-liver-metastasis-resection-insights-from-the-bio-crlm-study/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:10:34-08:00</news:publication_date><news:title>Primary Tumor Biology Predicts Recurrence and Survival Outcomes After Colorectal Liver Metastasis Resection: Insights from the BIO-CRLM Study</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/hormonal-contraception-bmi-trajectories/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:09:49-08:00</news:publication_date><news:title>激素避孕会影响BMI轨迹吗？丹麦大型队列研究揭示青春期到成年期的体重变化</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/hormonal-contraceptives-bmi-trajectory/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:09:32-08:00</news:publication_date><news:title>ホルモン避妊薬はBMIの推移にどう影響するか：デンマーク大規模コホートが示した知見</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/hormonal-contraception-bmi-trajectory/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:09:16-08:00</news:publication_date><news:title>Thuốc tránh thai nội tiết ảnh hưởng thế nào đến quỹ đạo BMI từ tuổi vị thành niên đến trưởng thành? Dữ liệu từ một đoàn hệ lớn ở Đan Mạch</news:title></news:news></url>
<url><loc>https://news.medxy.ai/impact-of-hormonal-contraceptive-use-on-bmi-trajectories-from-adolescence-to-adulthood-insights-from-a-large-danish-cohort/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:09:01-08:00</news:publication_date><news:title>Impact of Hormonal Contraceptive Use on BMI Trajectories from Adolescence to Adulthood: Insights from a Large Danish Cohort</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/noninvasive-variceal-screening/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:08:20-08:00</news:publication_date><news:title>Baveno VI标准再评估：SAPHE-R开启肝细胞癌静脉曲张无创筛查新路径</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/variceal-screening-strategy/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:08:00-08:00</news:publication_date><news:title>肝細胞癌における静脈瘤除外診断の新戦略：Baveno VIの検証とSAPHE-Rの提案</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/noninvasive-variceal-screening-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:07:37-08:00</news:publication_date><news:title>Xác thực Baveno VI và giới thiệu SAPHE-R: Một hướng tiếp cận không xâm lấn mới để loại trừ giãn tĩnh mạch ở bệnh nhân ung thư biểu mô tế bào gan</news:title></news:news></url>
<url><loc>https://news.medxy.ai/validating-baveno-vi-and-introducing-saphe-r-a-new-non-invasive-approach-to-rule-out-varices-in-hepatocellular-carcinoma-patients/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:07:18-08:00</news:publication_date><news:title>Validating Baveno VI and Introducing SAPHE-R: A New Non-Invasive Approach to Rule Out Varices in Hepatocellular Carcinoma Patients</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/behavioral-variant-frontotemporal-dementia-3/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:06:32-08:00</news:publication_date><news:title>以行为改变为首发表现的额颞叶痴呆中的人格改变与功能障碍研究</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/behavioral-variant-frontotemporal-dementia/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:06:11-08:00</news:publication_date><news:title>初期行動変異型前頭側頭型認知症における人格変化と機能障害：臨床的示唆と意義</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/behavioral-variant-frontotemporal-dementia-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:05:09-08:00</news:publication_date><news:title>Thay đổi nhân cách và suy giảm chức năng trong sa sút trí tuệ trán-thái dương thể biến đổi hành vi giai đoạn sớm: Các gợi ý và ý nghĩa lâm sàng</news:title></news:news></url>
<url><loc>https://news.medxy.ai/personality-changes-and-functional-impairment-in-early-behavioral-variant-frontotemporal-dementia-clinical-insights-and-implications/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:04:49-08:00</news:publication_date><news:title>Personality Changes and Functional Impairment in Early Behavioral Variant Frontotemporal Dementia: Clinical Insights and Implications</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/preventing-winter-vitamin-d-deficiency/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:04:04-08:00</news:publication_date><news:title>澳大利亚冬季维生素D缺乏怎么防：夏末25(OH)D需要达到多少？证据综述与临床启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/estimating-summer-vitamin-d-levels/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:03:39-08:00</news:publication_date><news:title>オーストラリアで冬季のビタミンD欠乏を防ぐための夏季25-ヒドロキシビタミンD濃度の推定：エビデンス統合と臨床的含意</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/estimating-summer-vitamin-d3-levels/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:03:14-08:00</news:publication_date><news:title>Phòng ngừa thiếu hụt vitamin D trong mùa đông tại Úc: Nồng độ 25(OH)D nên đạt mức nào vào cuối mùa hè? Tổng quan các bằng chứng và ý nghĩa lâm sàng</news:title></news:news></url>
<url><loc>https://news.medxy.ai/estimating-the-summer-25-hydroxyvitamin-d-concentration-needed-to-prevent-winter-vitamin-d-deficiency-in-australia-evidence-synthesis-and-clinical-implications/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:02:49-08:00</news:publication_date><news:title>Estimating the Summer 25-Hydroxyvitamin D Concentration Needed to Prevent Winter Vitamin D Deficiency in Australia: Evidence Synthesis and Clinical Implications</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/left-atrial-appendage-closure-unsuitable-for-oral-anticoagulation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T06:01:26-08:00</news:publication_date><news:title>对于被认为不适合接受口服抗凝治疗的患者进行左心耳封堵术：ASAP-TOO研究中长达5年的随机试验结果</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/left-atrial-appendage-closure-considered-unsuitable-for-oral-anticoagulation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T06:01:09-08:00</news:publication_date><news:title>経口抗凝固療法が不適当と判断された患者における左心耳閉鎖術：ASAP-TOO試験における5年間の無作為化試験成績</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/left-atrial-appendage-closure-in-patients-considered-unsuitable-for-oral-anticoagulation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T06:00:50-08:00</news:publication_date><news:title>Bít tiểu nhĩ trái ở những bệnh nhân được đánh giá là không phù hợp để dùng thuốc chống đông đường uống: Kết quả từ thử nghiệm ngẫu nhiên trong 5 năm (nghiên cứu ASAP-TOO)</news:title></news:news></url>
<url><loc>https://news.medxy.ai/long-term-outcomes-of-left-atrial-appendage-closure-in-atrial-fibrillation-patients-unsuitable-for-oral-anticoagulation-insights-from-the-asap-too-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T06:00:31-08:00</news:publication_date><news:title>Long-Term Outcomes of Left Atrial Appendage Closure in Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation: Insights from the ASAP-TOO Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/oral-nutrition-nasopharyngeal-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T05:59:39-08:00</news:publication_date><news:title>鼻咽癌同步放化疗中的口服营养补充：早期启动优于常规补充的随机试验证据与临床启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/early-nutrition-nasopharyngeal-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T05:59:15-08:00</news:publication_date><news:title>鼻咽頭癌の同時化学放射線療法における早期経口栄養補助は有効か――ランダム化試験からみたエビデンスと臨床的意義</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/early-nutrition-nasopharyngeal-cancer-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T05:58:51-08:00</news:publication_date><news:title>Trong liệu pháp hóa xạ trị đồng thời đối với ung thư vòm họng, việc bắt đầu bổ sung dinh dưỡng qua đường uống từ sớm mang lại hiệu quả vượt trội so với việc bổ sung dinh dưỡng theo quy trình thông thường</news:title></news:news></url>
<url><loc>https://news.medxy.ai/early-vs-routine-oral-nutritional-supplementation-during-concurrent-chemoradiotherapy-for-nasopharyngeal-carcinoma-evidence-and-clinical-implications-from-a-randomized-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T05:58:29-08:00</news:publication_date><news:title>Early vs Routine Oral Nutritional Supplementation During Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma: Evidence and Clinical Implications from a Randomized Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/cancer-rehabilitation-use/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T05:57:08-08:00</news:publication_date><news:title>World Trade Center Health Program におけるがん患者のリハビリテーション療法利用実態</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/rehabilitation-service-use-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T05:56:47-08:00</news:publication_date><news:title>Mức độ sử dụng dịch vụ phục hồi chức năng ở các thành viên Chương trình Sức khỏe World Trade Center mắc ung thư</news:title></news:news></url>
<url><loc>https://news.medxy.ai/use-of-rehabilitation-therapy-services-among-world-trade-center-health-program-members-with-cancer/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T05:56:33-08:00</news:publication_date><news:title>Use of Rehabilitation Therapy Services among World Trade Center Health Program Members with Cancer</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/class-ii-restoration-comparison/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T05:55:56-08:00</news:publication_date><news:title>Ⅱ类修复中分层充填与大块充填热黏弹性复合材料的临床效果比较：一项为期两年的随机裂口试验</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/class-ii-restoration-comparison-3/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T05:55:40-08:00</news:publication_date><news:title>Class II修復における段階充填法とbulk-fill法の臨床成績比較：温熱粘性コンポジットを用いた2年間無作為化分割口腔試験</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/class-ii-restoration-comparison-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T05:55:19-08:00</news:publication_date><news:title>Phục hồi loại II: So sánh hiệu quả lâm sàng giữa kỹ thuật đặt từng lớp và bulk-fill với composite nhiệt nhớt trong thử nghiệm ngẫu nhiên split-mouth kéo dài 2 năm</news:title></news:news></url>
<url><loc>https://news.medxy.ai/comparative-clinical-performance-of-incremental-versus-bulk-fill-thermoviscous-composite-techniques-in-class-ii-restorations-a-two-year-randomized-split-mouth-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T05:55:04-08:00</news:publication_date><news:title>Comparative Clinical Performance of Incremental Versus Bulk-Fill Thermoviscous Composite Techniques in Class II Restorations: A Two-Year Randomized Split-Mouth Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/prasugrel-vs-ticagrelor-acute-coronary-syndrome/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-22T05:54:24-08:00</news:publication_date><news:title>普拉格雷与替格瑞洛用于急性冠状动脉综合征：来自SWITCH-SWEDEHEART试验的启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/prasugrel-and-ticagrelor-acute-coronary-syndrome/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-22T05:54:09-08:00</news:publication_date><news:title>急性冠状動脈症候群におけるプラスグレルとチカグレロル：SWITCH-SWEDEHEART試験からの示唆</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/prasugrel-vs-ticagrelor-acute-coronary-syndrome-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-22T05:53:50-08:00</news:publication_date><news:title>Prasugrel hay Ticagrelor trong hội chứng vành cấp: Những phát hiện từ thử nghiệm SWITCH-SWEDEHEART</news:title></news:news></url>
<url><loc>https://news.medxy.ai/comparing-prasugrel-and-ticagrelor-for-acute-coronary-syndromes-insights-from-the-switch-swedeheart-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-22T05:53:33-08:00</news:publication_date><news:title>Comparing Prasugrel and Ticagrelor for Acute Coronary Syndromes: Insights from the SWITCH-SWEDEHEART Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/alxn1840-phase-3-breakthrough-shifting-wilson-disease-care-from-copper-control-to-neurologic-recovery/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T19:16:00-08:00</news:publication_date><news:title>ALXN1840 Phase 3 Breakthrough: Shifting Wilson Disease Care from Copper Control to Neurologic Recovery</news:title></news:news></url>
<url><loc>https://news.medxy.ai/why-plain-water-can-be-dangerous-for-babies-the-science-behind-infant-water-intoxication/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T16:10:00-08:00</news:publication_date><news:title>Why Plain Water Can Be Dangerous for Babies: The Science Behind Infant Water Intoxication</news:title></news:news></url>
<url><loc>https://news.medxy.ai/is-infidelity-just-zero-times-or-countless-times-scientists-tracked-484-people-and-found-its-not-that-simple/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T15:57:41-08:00</news:publication_date><news:title>Is Infidelity Just &#8220;Zero Times or Countless Times&#8221;? Scientists Tracked 484 People and Found It&#8217;s Not That Simple</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/2026-global-hypertension-guidelines-130-80-elevated-blood-pressure/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T15:47:55-08:00</news:publication_date><news:title>2026年グローバル血圧ガイドラインで、130/80 mmHgがもはや「ほぼ正常」ではない理由</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/130-80-blood-pressure-guidelines/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T15:44:33-08:00</news:publication_date><news:title>为什么在2026年全球血压指南下，130/80 mmHg不再算“接近正常”</news:title></news:news></url>
<url><loc>https://news.medxy.ai/why-130-80-mmhg-is-no-longer-close-to-normal-under-the-2026-global-blood-pressure-guidelines/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T15:36:00-08:00</news:publication_date><news:title>Why 130/80 mmHg Is No Longer &#8220;Close to Normal&#8221; Under the 2026 Global Blood Pressure Guidelines</news:title></news:news></url>
<url><loc>https://news.medxy.ai/oral-ar1001-hits-primary-endpoint-in-prespecified-early-ad-monotherapy-cohort-at-ctad-2026/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T13:03:00-08:00</news:publication_date><news:title>Oral AR1001 Hits Primary Endpoint in Prespecified Early AD Monotherapy Cohort at CTAD 2026</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/ethical-dilemmas-prenatal-testing/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T05:00:27-08:00</news:publication_date><news:title>产前检测的伦理抉择：成年期起病遗传性疾病中的两难与思考</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/ethical-dilemmas-prenatal-testing-huntington-disease/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T05:00:00-08:00</news:publication_date><news:title>出生前検査における倫理的選択：成人発症の遺伝性疾患に見られるジレンマと考察</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/ethical-dilemmas-prenatal-testing-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:59:32-08:00</news:publication_date><news:title>Các lựa chọn đạo đức trong xét nghiệm trước sinh đối với bệnh Huntington: Những tình huống tiến thoái lưỡng nan và suy ngẫm về các rối loạn di truyền khởi phát ở tuổi trưởng thành</news:title></news:news></url>
<url><loc>https://news.medxy.ai/navigating-the-ethical-crossroads-of-prenatal-testing-for-adult-onset-genetic-conditions-the-case-of-huntington-disease/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:59:08-08:00</news:publication_date><news:title>Navigating the Ethical Crossroads of Prenatal Testing for Adult-Onset Genetic Conditions: The Case of Huntington Disease</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/genetic-biomarkers-giant-cell-arteritis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:58:28-08:00</news:publication_date><news:title>遗传生物标志物揭示巨细胞动脉炎的不同临床亚组：诊断与个体化管理的新启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/genetic-biomarkers-giant-cell-arteritis-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:58:07-08:00</news:publication_date><news:title>巨細胞性動脈炎の臨床サブグループを規定する遺伝学的バイオマーカー：診断と個別化管理への示唆</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/genetic-biomarkers-giant-cell-arteritis-3/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:57:44-08:00</news:publication_date><news:title>Các dấu ấn sinh học di truyền tiết lộ những phân nhóm lâm sàng riêng biệt của bệnh viêm động mạch tế bào khổng lồ: Những hiểu biết mới phục vụ chẩn đoán và quản lý cá thể hóa</news:title></news:news></url>
<url><loc>https://news.medxy.ai/genetic-biomarkers-define-distinct-clinical-subgroups-in-giant-cell-arteritis-implications-for-diagnosis-and-personalized-management/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:57:22-08:00</news:publication_date><news:title>Genetic Biomarkers Define Distinct Clinical Subgroups in Giant Cell Arteritis: Implications for Diagnosis and Personalized Management</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/clad-monitoring-with-alveolar-nitric-oxide/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:56:44-08:00</news:publication_date><news:title>CLAD监测新思路：将肺泡一氧化氮纳入肺移植随访评估</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/refining-clad-surveillance/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:56:23-08:00</news:publication_date><news:title>CLADサーベイランスを磨く：肺胞一酸化窒素を組み込んだ新たな肺移植モニタリング</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/clad-monitoring-upgrade/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:56:00-08:00</news:publication_date><news:title>Nâng cấp giám sát CLAD: Tích hợp nitric oxide phế nang để theo dõi ghép phổi hiệu quả hơn</news:title></news:news></url>
<url><loc>https://news.medxy.ai/refining-clad-surveillance-integrating-alveolar-nitric-oxide-for-enhanced-lung-transplant-monitoring/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:55:42-08:00</news:publication_date><news:title>Refining CLAD Surveillance: Integrating Alveolar Nitric Oxide for Enhanced Lung Transplant Monitoring</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/cancer-risk-scleroderma/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:55:05-08:00</news:publication_date><news:title>局限性硬皮病与系统性硬化症的癌症风险各异：一项大型人群队列研究的新发现</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/cancer-risk-scleroderma-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:54:46-08:00</news:publication_date><news:title>限局性強皮症と全身性強皮症にみられる異なるがんリスク：大規模集団ベースコホート研究からの知見</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/cancer-risk-scleroderma-and-ss/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:54:24-08:00</news:publication_date><news:title>Sự khác biệt về nguy cơ ung thư giữa bệnh xơ cứng bì khu trú và bệnh xơ cứng bì hệ thống: Những phát hiện mới từ một nghiên cứu đoàn hệ quy mô lớn dựa trên quần thể</news:title></news:news></url>
<url><loc>https://news.medxy.ai/distinct-cancer-risks-in-morphea-and-systemic-sclerosis-insights-from-a-large-population-based-cohort-study/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:54:04-08:00</news:publication_date><news:title>Distinct Cancer Risks in Morphea and Systemic Sclerosis: Insights from a Large Population-Based Cohort Study</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/optimizing-lymphaticovenous-anastomosis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:53:26-08:00</news:publication_date><news:title>优化淋巴静脉吻合：影响淋巴水肿手术疗效的关键术中因素</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/optimizing-lymphaticovenous-anastomosis-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:53:08-08:00</news:publication_date><news:title>リンパ管静脈吻合術の最適化：リンパ浮腫手術の治療成績に影響を及ぼす術中の重要な要因</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/optimizing-lymphatic-venous-anastomosis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:52:45-08:00</news:publication_date><news:title>Tối ưu hóa nối bạch huyết-tĩnh mạch: Những yếu tố trong mổ quyết định kết quả tốt hơn trong phẫu thuật phù bạch huyết</news:title></news:news></url>
<url><loc>https://news.medxy.ai/refining-lymphovenous-anastomosis-intraoperative-factors-driving-improved-outcomes-in-lymphedema-surgery/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:52:26-08:00</news:publication_date><news:title>Refining Lymphovenous Anastomosis: Intraoperative Factors Driving Improved Outcomes in Lymphedema Surgery</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/university-mental-health-care/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:51:47-08:00</news:publication_date><news:title>AI时代的大学心理健康转型：从危机应对到整合式照护</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/university-mental-health-reform/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:51:27-08:00</news:publication_date><news:title>AI時代の大学メンタルヘルス改革：危機対応から統合ケアへ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/university-mental-health-ai-era/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:51:05-08:00</news:publication_date><news:title>Chuyển đổi sức khỏe tâm thần đại học trong kỷ nguyên AI: Từ khủng hoảng đến chăm sóc tích hợp</news:title></news:news></url>
<url><loc>https://news.medxy.ai/transforming-university-mental-health-in-the-ai-era-from-crisis-to-integrated-care/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:50:45-08:00</news:publication_date><news:title>Transforming University Mental Health in the AI Era: From Crisis to Integrated Care</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/news-2-triggered-sepsis-bundle/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:50:08-08:00</news:publication_date><news:title>NEWS-2 触发的急诊脓毒症 Hour-1 方案：来自 NEWS-1 TRIPS 试点试验的启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/news-2-sepsis-bundle/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:49:48-08:00</news:publication_date><news:title>救急部門におけるNEWS-2起動型Hour-1敗血症バンドルの評価：NEWS-1 TRIPSパイロット試験からの知見</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/news-2-sepsis-intervention/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:49:10-08:00</news:publication_date><news:title>NEWS-2 có thực sự hữu ích để kích hoạt gói can thiệp sepsis giờ đầu tại khoa cấp cứu? Bằng chứng ban đầu từ thử nghiệm thí điểm NEWS-1 TRIPS</news:title></news:news></url>
<url><loc>https://news.medxy.ai/evaluating-news-2-guided-hour-1-sepsis-bundle-in-emergency-departments-insights-from-the-news-1-trips-pilot-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:48:49-08:00</news:publication_date><news:title>Evaluating NEWS-2 Guided Hour-1 Sepsis Bundle in Emergency Departments: Insights from the NEWS-1 TRIPS Pilot Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/ember-trial-veteran-weight-management-feedback/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:48:09-08:00</news:publication_date><news:title>EMBER試験：退役軍人の体重管理参加を促進する自主学習型動機づけツールのハイブリッド第1種ランダム化臨床試験</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/ember-trial-veteran-weight-management/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:47:50-08:00</news:publication_date><news:title>Thử nghiệm EMBER: Thử nghiệm lâm sàng ngẫu nhiên hỗn hợp loại 1 về công cụ tạo động lực tự hướng dẫn nhằm thu hút cựu chiến binh tham gia quản lý cân nặng</news:title></news:news></url>
<url><loc>https://news.medxy.ai/the-ember-trial-a-hybrid-type-1-randomized-clinical-trial-of-a-self-guided-motivational-tool-to-engage-veterans-in-weight-management/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:47:32-08:00</news:publication_date><news:title>The EMBER Trial: A Hybrid Type 1 Randomized Clinical Trial of a Self-Guided Motivational Tool to Engage Veterans in Weight Management</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/nur77-regulates-diabetic-anemia/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:46:57-08:00</news:publication_date><news:title>Nur77：通过造血谱系调控阻止糖尿病贫血的关键分子</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/nur77-prevents-diabetic-anemia/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:46:36-08:00</news:publication_date><news:title>Nur77による造血系統制御が糖尿病性貧血を防ぐ鍵となる</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/nur77-diabetic-anemia-regulator/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:46:15-08:00</news:publication_date><news:title>Nur77: Bộ điều hòa then chốt giúp ngăn ngừa thiếu máu do đái tháo đường thông qua kiểm soát dòng tạo máu</news:title></news:news></url>
<url><loc>https://news.medxy.ai/nur77-a-key-regulator-preventing-diabetic-anemia-through-hematopoietic-lineage-control/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:45:56-08:00</news:publication_date><news:title>Nur77: A Key Regulator Preventing Diabetic Anemia Through Hematopoietic Lineage Control</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/sepsis-time-zero-criteria/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:45:20-08:00</news:publication_date><news:title>重塑脓毒症“time zero”：找出影响抗生素给药时机与死亡结局的器官功能障碍标准</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/revisiting-sepsis-time-zero/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:44:58-08:00</news:publication_date><news:title>敗血症の「time zero」を見直す：抗菌薬投与時期と死亡転帰に影響する臓器障害基準の特定</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/sepsis-time-zero-criteria-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:44:33-08:00</news:publication_date><news:title>Tinh chỉnh “time zero” của sepsis: xác định các tiêu chí rối loạn chức năng cơ quan ảnh hưởng đến thời điểm kháng sinh và kết cục tử vong</news:title></news:news></url>
<url><loc>https://news.medxy.ai/refining-sepsis-time-zero-identifying-organ-dysfunction-criteria-that-impact-antibiotic-timing-and-mortality-outcomes/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:44:08-08:00</news:publication_date><news:title>Refining Sepsis Time Zero: Identifying Organ Dysfunction Criteria that Impact Antibiotic Timing and Mortality Outcomes</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/faricimab-diabetic-macular-edema-4-year-results/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:43:29-08:00</news:publication_date><news:title>Faricimab 治疗糖尿病黄斑水肿的 4 年疗效：来自 RHONE-X 扩展研究及相关证据的启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/faricimab-diabetic-macular-edema-four-year-results/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:43:07-08:00</news:publication_date><news:title>糖尿病黄斑浮腫に対するFaricimabの4年成績：RHONE-X延長試験と関連エビデンスからの示唆</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/faricimab-diabetic-macular-edema-four-year-results-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:42:42-08:00</news:publication_date><news:title>Kết quả 4 năm sử dụng Faricimab cho bệnh phù hoàng điểm do đái tháo đường: Những gợi ý từ nghiên cứu mở rộng RHONE-X và các bằng chứng liên quan</news:title></news:news></url>
<url><loc>https://news.medxy.ai/four-year-outcomes-of-faricimab-in-diabetic-macular-edema-insights-from-the-rhone-x-extension-trial-and-related-evidence/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:42:22-08:00</news:publication_date><news:title>Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Insights from the RHONE-X Extension Trial and Related Evidence</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/dacryocystorhinostomy-efficacy-comparison/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:41:27-08:00</news:publication_date><news:title>外路与动力辅助内镜下泪囊鼻腔造口术联合丝裂霉素C治疗鼻泪管阻塞的疗效比较：一项随机对照试验</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/dacryocystorhinostomy-efficacy-comparison-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:41:05-08:00</news:publication_date><news:title>鼻涙管閉塞に対するマイトマイシンC併用・外切開法および動力補助内視鏡下涙嚢鼻腔吻合術の治療成績の比較：ランダム化比較試験</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/dacryocystorhinostomy-comparison/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:40:43-08:00</news:publication_date><news:title>So sánh kết quả phẫu thuật nối thông túi lệ &#8211; mũi qua đường ngoài và nội soi có hỗ trợ dụng cụ tạo lực kèm Mitomycin C trong tắc ống lệ mũi: thử nghiệm ngẫu nhiên có đối chứng</news:title></news:news></url>
<url><loc>https://news.medxy.ai/comparative-outcomes-of-external-versus-powered-endoscopic-dacryocystorhinostomy-with-mitomycin-c-in-nasolacrimal-duct-obstruction-a-randomized-controlled-trial/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:40:22-08:00</news:publication_date><news:title>Comparative Outcomes of External versus Powered Endoscopic Dacryocystorhinostomy with Mitomycin C in Nasolacrimal Duct Obstruction: A Randomized Controlled Trial</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/late-preterm-steroid-practice-variation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:39:44-08:00</news:publication_date><news:title>晚期早产产前糖皮质激素使用的医院差异：美国实践不均衡的揭示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/late-preterm-steroid-practice-variation-2/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:39:20-08:00</news:publication_date><news:title>後期早産における出生前糖質コルチコイド使用の施設間差：米国の診療における不均衡の露呈</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/antenatal-corticosteroids-late-preterm/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:38:55-08:00</news:publication_date><news:title>Sử dụng corticosteroid trước sinh cho sinh non muộn: Sự khác biệt giữa các bệnh viện tại Hoa Kỳ</news:title></news:news></url>
<url><loc>https://news.medxy.ai/hospital-level-variation-in-antenatal-corticosteroid-use-for-late-preterm-births-unveiling-practice-disparities-in-the-united-states/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:38:33-08:00</news:publication_date><news:title>Hospital-Level Variation in Antenatal Corticosteroid Use for Late Preterm Births: Unveiling Practice Disparities in the United States</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/par2-ibuprofen-pain-ibd-itching/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:37:53-08:00</news:publication_date><news:title>PAR2内体信号放大IBS组胺致痛：机制解析与临床启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/par2-signaling-amplifies-pain/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:37:32-08:00</news:publication_date><news:title>エンドソームで続くPAR2シグナルが、過敏性腸症候群のヒスタミン誘発痛を増幅する：機序と臨床的意義</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/protease-activated-receptor-2-pain/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:37:08-08:00</news:publication_date><news:title>Tín hiệu thể nội bào của thụ thể hoạt hóa bởi protease-2 khuếch đại đau do histamine trong hội chứng ruột kích thích: Những hiểu biết cơ chế và ý nghĩa lâm sàng</news:title></news:news></url>
<url><loc>https://news.medxy.ai/endosomal-signalling-of-protease-activated-receptor-2-amplifies-histamine-induced-pain-in-irritable-bowel-syndrome-mechanistic-insights-and-clinical-implications/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:36:47-08:00</news:publication_date><news:title>Endosomal Signalling of Protease-Activated Receptor-2 Amplifies Histamine-Induced Pain in Irritable Bowel Syndrome: Mechanistic Insights and Clinical Implications</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/mivocabtagene-stiff-person-syndrome/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:36:02-08:00</news:publication_date><news:title>Mivocabtagene Autoleucel用于僵人综合征的CD19 CAR T细胞治疗：疗效、安全性及新兴临床范式</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/mivocabtagene-car-t-in-stiff-person-syndrome/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:35:43-08:00</news:publication_date><news:title>僵人综合征中的Mivocabtagene Autoleucel CD19 CAR T细胞治疗：疗效、安全性与新兴临床范式</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/mivocabtagene-autoleucel-in-stiff-person-syndrome/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:35:19-08:00</news:publication_date><news:title>Mivocabtagene Autoleucel: Bước tiến mới của liệu pháp tế bào T CAR CD19 trong hội chứng người cứng</news:title></news:news></url>
<url><loc>https://news.medxy.ai/mivocabtagene-autoleucel-cd19-car-t-cell-therapy-in-stiff-person-syndrome-efficacy-safety-and-emerging-clinical-paradigm/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:35:00-08:00</news:publication_date><news:title>Mivocabtagene Autoleucel CD19 CAR T-Cell Therapy in Stiff Person Syndrome: Efficacy, Safety, and Emerging Clinical Paradigm</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/refractory-autoimmune-hypophysitis-management/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:34:13-08:00</news:publication_date><news:title>难治性原发性自身免疫性垂体炎如何识别与管理？——回顾性队列研究带来的启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/diagnosing-treating-autoimmune-hypophysitis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:33:53-08:00</news:publication_date><news:title>難治性原発性自己免疫性下垂体炎をどう診断し、どう治療するか：後ろ向きコホート研究からの示唆</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/refractory-autoimmune-hypophysitis/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:33:29-08:00</news:publication_date><news:title>Viêm tuyến yên tự miễn nguyên phát kháng trị: nhận diện sớm và chiến lược xử trí từ nghiên cứu đoàn hệ hồi cứu</news:title></news:news></url>
<url><loc>https://news.medxy.ai/defining-and-managing-refractory-primary-autoimmune-hypophysitis-insights-from-a-retrospective-cohort-study/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:33:18-08:00</news:publication_date><news:title>Defining and Managing Refractory Primary Autoimmune Hypophysitis: Insights from a Retrospective Cohort Study</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/ischemic-heart-disease-treatment/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:32:43-08:00</news:publication_date><news:title>晚期慢性肾脏病合并稳定性冠状动脉疾病：侵入性治疗还是保守治疗更有利？——来自 ISCHEMIA-CKD EXTEND 的长期结局</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/long-term-outcomes-ischemia-ckd/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:32:23-08:00</news:publication_date><news:title>進行したCKDを伴う安定冠動脈疾患における侵襲的管理と保存的管理の長期転帰：ISCHEMIA-CKD EXTENDからの知見</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/long-term-outcomes-in-advanced-ckd/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:31:59-08:00</news:publication_date><news:title>Kết cục dài hạn giữa chiến lược xâm lấn và bảo tồn ở bệnh động mạch vành ổn định kèm CKD tiến triển: dữ liệu từ ISCHEMIA-CKD EXTEND</news:title></news:news></url>
<url><loc>https://news.medxy.ai/long-term-outcomes-of-invasive-versus-conservative-management-in-stable-coronary-disease-with-advanced-ckd-insights-from-ischemia-ckd-extend/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:31:38-08:00</news:publication_date><news:title>Long-Term Outcomes of Invasive Versus Conservative Management in Stable Coronary Disease with Advanced CKD: Insights from ISCHEMIA-CKD EXTEND</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/low-muscle-power-mortality-risk/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:31:01-08:00</news:publication_date><news:title>血液透析患者低肌肉机械功率能否预示死亡风险？——来自SARC-HD队列的研究启示</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/low-muscle-power-mortality/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:30:41-08:00</news:publication_date><news:title>血液透析患者の死亡予測因子としての低筋機械的パワー：SARC-HDコホートからの知見</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/low-mechanical-power-predicts-mortality/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:30:17-08:00</news:publication_date><news:title>Công suất cơ học cơ thấp có dự báo tử vong ở bệnh nhân chạy thận nhân tạo không? Bằng chứng từ đoàn hệ SARC-HD</news:title></news:news></url>
<url><loc>https://news.medxy.ai/low-muscle-mechanical-power-as-a-predictor-of-mortality-in-hemodialysis-patients-insights-from-the-sarc-hd-cohort/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:29:58-08:00</news:publication_date><news:title>Low Muscle Mechanical Power as a Predictor of Mortality in Hemodialysis Patients: Insights from the SARC-HD Cohort</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/physiological-effects-exercise-training/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:29:18-08:00</news:publication_date><news:title>早期心脏康复中低容量高强度间歇训练与中等强度持续训练的生理效应比较</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/physiological-effects-exercise-training-hiit/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:28:58-08:00</news:publication_date><news:title>心臓リハビリテーション早期における低容量高強度インターバルトレーニングと中等強度持続的トレーニングの比較</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/physiological-effects-hiit-exercise-training/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:28:34-08:00</news:publication_date><news:title>So sánh tác động của tập luyện ngắt quãng cường độ cao với khối lượng thấp và tập luyện liên tục cường độ trung bình trong giai đoạn đầu phục hồi chức năng tim</news:title></news:news></url>
<url><loc>https://news.medxy.ai/comparative-physiological-impacts-of-low-volume-high-intensity-interval-training-versus-moderate-intensity-continuous-training-in-early-cardiac-rehabilitation/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:28:14-08:00</news:publication_date><news:title>Comparative Physiological Impacts of Low-Volume High-Intensity Interval Training Versus Moderate-Intensity Continuous Training in Early Cardiac Rehabilitation</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/implant-bone-stability-11-years-outcome/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:27:33-08:00</news:publication_date><news:title>种植体周围边缘骨能否长期保持稳定？——数字化与传统修复方案的对比研究（随访期长达11.6年）</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/implant-bone-stability/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:27:09-08:00</news:publication_date><news:title>インプラント周囲辺縁骨は長期に安定するか：デジタルと従来法の補綴アプローチを11.6年まで比較</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/implant-bone-stability-over-11-years-outcome/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:26:44-08:00</news:publication_date><news:title>Xương viền quanh implant có ổn định lâu dài không: So sánh các phương pháp phục hình kỹ thuật số và truyền thống trong thời gian theo dõi lên đến 11,6 năm</news:title></news:news></url>
<url><loc>https://news.medxy.ai/long-term-stability-of-peri-implant-crestal-bone-comparative-insights-between-digital-and-conventional-restorative-approaches-over-up-to-11-6-years/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:26:26-08:00</news:publication_date><news:title>Long-Term Stability of Peri-Implant Crestal Bone: Comparative Insights Between Digital and Conventional Restorative Approaches Over Up to 11.6 Years</news:title></news:news></url>
<url><loc>https://news.medxy.ai/zh/venous-thrombosis-prevention/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>zh</news:language></news:publication><news:publication_date>2026-11-21T04:25:47-08:00</news:publication_date><news:title>髋膝关节置换术后静脉血栓栓塞预防：阿司匹林、华法林与利伐沙班的比较</news:title></news:news></url>
<url><loc>https://news.medxy.ai/ja/vte-prevention-after-joint-replacement/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>ja</news:language></news:publication><news:publication_date>2026-11-21T04:25:25-08:00</news:publication_date><news:title>人工股関節・膝関節置換術後のVTE予防：アスピリン、ワルファリン、リバーロキサバンを比較</news:title></news:news></url>
<url><loc>https://news.medxy.ai/vi/aspirin-warfarin-rivaroxaban-thrombosis-prevention/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>vi</news:language></news:publication><news:publication_date>2026-11-21T04:24:59-08:00</news:publication_date><news:title>Aspirin, warfarin và rivaroxaban: thuốc nào tối ưu để phòng ngừa huyết khối tĩnh mạch thuyên tắc sau thay khớp háng hoặc khớp gối?</news:title></news:news></url>
<url><loc>https://news.medxy.ai/comparing-aspirin-warfarin-and-rivaroxaban-for-preventing-venous-thromboembolism-after-hip-or-knee-replacement/</loc><news:news><news:publication><news:name>Medxy AI</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-21T04:24:39-08:00</news:publication_date><news:title>Comparing Aspirin, Warfarin, and Rivaroxaban for Preventing Venous Thromboembolism After Hip or Knee Replacement</news:title></news:news></url>
</urlset>
